CISPLATIN

CISPLATIN was reported 79025 times

CISPLATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OVARIAN GERM CELL TERATOMA 36 0.4500
1 RENAL SALT-WASTING SYNDROME 161 0.4107
2 RADIATION MUCOSITIS 43 0.2671
3 TERATOMA 55 0.2558
4 OESOPHAGOBRONCHIAL FISTULA 36 0.2368
5 REFRACTORY CANCER 50 0.2336
6 OESOPHAGEAL FISTULA 70 0.2201
7 MENINGITIS TUBERCULOUS 115 0.2057
8 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 194 0.2049
9 RADIATION OESOPHAGITIS 78 0.2047
10 CHEMICAL PERITONITIS 37 0.1869
11 BLOOD STEM CELL TRANSPLANT FAILURE 40 0.1860
12 CERVIX CARCINOMA RECURRENT 32 0.1798
13 OSTEOSARCOMA 67 0.1740
14 OTOTOXICITY 316 0.1707
15 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 373 0.1690
16 OSTEORADIONECROSIS 37 0.1667
17 MALIGNANT TRANSFORMATION 74 0.1648
18 AORTIC THROMBOSIS 188 0.1626
19 UROGENITAL FISTULA 35 0.1477
20 CENTRAL HYPOTHYROIDISM 45 0.1360
21 MANTLE CELL LYMPHOMA RECURRENT 58 0.1333
22 ANASTOMOTIC LEAK 87 0.1254
23 B-CELL LYMPHOMA RECURRENT 64 0.1179
24 PORTAL VENOUS GAS 41 0.1129
25 THROMBOPHLEBITIS MIGRANS 38 0.1118
26 RADIATION SKIN INJURY 129 0.1112
27 CYTOMEGALOVIRUS OESOPHAGITIS 37 0.1005
28 HAEMATOTOXICITY 900 0.0946
29 NEUROBLASTOMA 35 0.0914
30 NEUTROPENIC SEPSIS 644 0.0901
31 IMMUNE-MEDIATED RENAL DISORDER 37 0.0894
32 PLASMA CELL LEUKAEMIA 51 0.0850
33 FOLLICULAR LYMPHOMA 72 0.0818
34 OESOPHAGEAL PERFORATION 68 0.0815
35 RECALL PHENOMENON 68 0.0813
36 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 63 0.0806
37 GASTROINTESTINAL TOXICITY 387 0.0805
38 MYELOSUPPRESSION 2846 0.0789
39 CHLOROMA 33 0.0782
40 RADIATION PNEUMONITIS 167 0.0780
41 MUCOSAL INFLAMMATION 1958 0.0747
42 BONE MARROW TOXICITY 86 0.0726
43 THERAPY RESPONDER 35 0.0713
44 FEBRILE NEUTROPENIA 4684 0.0705
45 TUMOUR NECROSIS 74 0.0700
46 HYPERCREATININAEMIA 35 0.0696
47 PULMONARY VASCULAR DISORDER 32 0.0679
48 NEUTROPENIC COLITIS 135 0.0652
49 SALIVARY GLAND CANCER 32 0.0649
50 IMMUNE-MEDIATED ENCEPHALITIS 34 0.0643
51 TRACHEO-OESOPHAGEAL FISTULA 41 0.0642
52 METASTASES TO SKIN 65 0.0629
53 NEPHROPATHY TOXIC 703 0.0626
54 NEUTROPENIC INFECTION 59 0.0617
55 VENA CAVA THROMBOSIS 102 0.0613
56 IMMUNE-MEDIATED HYPOTHYROIDISM 69 0.0612
57 TRANSITIONAL CELL CARCINOMA 79 0.0609
58 IMMUNE-MEDIATED DERMATITIS 60 0.0595
59 ORAL INTAKE REDUCED 144 0.0595
60 CULTURE URINE POSITIVE 83 0.0590
61 METASTASES TO ADRENALS 53 0.0574
62 THERAPY PARTIAL RESPONDER 884 0.0566
63 ACQUIRED GENE MUTATION 71 0.0542
64 IMMUNE-MEDIATED HEPATIC DISORDER 105 0.0538
65 GRANULOCYTE COUNT DECREASED 96 0.0517
66 ADENOCARCINOMA GASTRIC 48 0.0517
67 AORTITIS 35 0.0510
68 CHOLANGITIS 315 0.0508
69 DIFFUSE LARGE B-CELL LYMPHOMA 391 0.0507
70 IMMUNE-MEDIATED LUNG DISEASE 92 0.0504
71 HYPOMAGNESAEMIA 699 0.0502
72 PLASMA CELL MYELOMA REFRACTORY 67 0.0501
73 PERIPHERAL ARTERY THROMBOSIS 69 0.0491
74 SECOND PRIMARY MALIGNANCY 407 0.0489
75 BONE MARROW FAILURE 994 0.0489
76 TUMOUR LYSIS SYNDROME 424 0.0481
77 METASTASES TO PERITONEUM 120 0.0475
78 APLASIA 93 0.0474
79 PARANEOPLASTIC SYNDROME 32 0.0473
80 FEBRILE BONE MARROW APLASIA 201 0.0472
81 ACUTE MYELOID LEUKAEMIA 733 0.0470
82 RADIATION INJURY 49 0.0461
83 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 37 0.0455
84 ARTERIAL THROMBOSIS 88 0.0455
85 OESOPHAGITIS 496 0.0454
86 BONE MARROW DEPRESSION 43 0.0441
87 SUBCLAVIAN VEIN THROMBOSIS 50 0.0439
88 MYELODYSPLASTIC SYNDROME 635 0.0439
89 PSEUDOMONAL BACTERAEMIA 37 0.0433
90 IMMUNE-MEDIATED MYOCARDITIS 70 0.0433
91 EMBOLISM ARTERIAL 52 0.0433
92 LYMPHANGIOSIS CARCINOMATOSA 45 0.0432
93 NEOPLASM RECURRENCE 145 0.0427
94 RENAL INFARCT 61 0.0421
95 DRUG CLEARANCE DECREASED 55 0.0421
96 DEAFNESS NEUROSENSORY 138 0.0419
97 CAROTID ARTERY THROMBOSIS 35 0.0412
98 TUMOUR PSEUDOPROGRESSION 45 0.0411
99 BLOOD CULTURE POSITIVE 123 0.0410
100 SYSTEMIC INFECTION 66 0.0398
101 DISEASE PROGRESSION 4706 0.0397
102 NEUTROPHIL COUNT ABNORMAL 112 0.0396
103 PNEUMATOSIS INTESTINALIS 113 0.0396
104 TUMOUR HAEMORRHAGE 113 0.0396
105 ENTEROCOCCAL SEPSIS 32 0.0395
106 GASTRIC PERFORATION 107 0.0392
107 NEUTROPHIL COUNT DECREASED 1596 0.0391
108 CHOLANGIOCARCINOMA 58 0.0389
109 CARDIOTOXICITY 346 0.0388
110 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 48 0.0385
111 CATHETER RELATED INFECTION 39 0.0385
112 FANCONI SYNDROME 54 0.0382
113 BLOOD CHLORIDE DECREASED 98 0.0380
114 PHARYNGEAL INFLAMMATION 46 0.0378
115 RENAL TUBULAR DISORDER 106 0.0376
116 PERIPHERAL ISCHAEMIA 152 0.0372
117 METASTASES TO PLEURA 39 0.0372
118 METASTASES TO LYMPH NODES 248 0.0367
119 PERIPHERAL SENSORY NEUROPATHY 212 0.0362
120 NEUTROPENIA 4930 0.0362
121 METASTASES TO LUNG 414 0.0358
122 PULMONARY TOXICITY 253 0.0357
123 KLEBSIELLA SEPSIS 40 0.0355
124 ODYNOPHAGIA 209 0.0350
125 OESOPHAGEAL STENOSIS 99 0.0348
126 PANCYTOPENIA 1942 0.0347
127 ENTEROCOLITIS INFECTIOUS 32 0.0347
128 THROMBOCYTOPENIA 3876 0.0346
129 VENOOCCLUSIVE LIVER DISEASE 171 0.0346
130 IMMUNE-MEDIATED ENTEROCOLITIS 127 0.0345
131 LIVER ABSCESS 111 0.0342
132 STREPTOCOCCAL BACTERAEMIA 37 0.0340
133 LEUKOPENIA 1700 0.0340
134 FEMALE GENITAL TRACT FISTULA 58 0.0339
135 LUNG ADENOCARCINOMA 102 0.0339
136 METASTASES TO CENTRAL NERVOUS SYSTEM 437 0.0338
137 KLEBSIELLA BACTERAEMIA 32 0.0337
138 ELECTROLYTE IMBALANCE 390 0.0335
139 LEUKOENCEPHALOPATHY 125 0.0335
140 BICYTOPENIA 65 0.0331
141 ENTEROCOCCAL BACTERAEMIA 35 0.0330
142 METASTASES TO MENINGES 75 0.0330
143 LOBAR PNEUMONIA 61 0.0329
144 MALIGNANT NEOPLASM PROGRESSION 3368 0.0329
145 EMPYEMA 65 0.0327
146 SPLENIC INFARCTION 57 0.0326
147 SMALL CELL LUNG CANCER 49 0.0324
148 HYPOALBUMINAEMIA 251 0.0322
149 CYTOPENIA 394 0.0321
150 EXTREMITY NECROSIS 56 0.0321
151 DEAFNESS BILATERAL 54 0.0317
152 HYPERAMMONAEMIC ENCEPHALOPATHY 55 0.0316
153 OVARIAN CANCER RECURRENT 50 0.0311
154 CYSTITIS HAEMORRHAGIC 123 0.0305
155 CLOSTRIDIUM COLITIS 37 0.0305
156 LYMPHADENOPATHY MEDIASTINAL 58 0.0303
157 RESPIRATORY ALKALOSIS 49 0.0301
158 BONE MARROW DISORDER 91 0.0301
159 STEM CELL TRANSPLANT 75 0.0300
160 PERFORMANCE STATUS DECREASED 139 0.0298
161 NON-SMALL CELL LUNG CANCER 141 0.0294
162 GASTROINTESTINAL PERFORATION 122 0.0293
163 CATHETER RELATED COMPLICATION 33 0.0293
164 PERIPHERAL MOTOR NEUROPATHY 41 0.0292
165 PLASMACYTOMA 54 0.0290
166 STAPHYLOCOCCUS TEST POSITIVE 61 0.0289
167 INFECTIOUS PLEURAL EFFUSION 44 0.0289
168 OESOPHAGEAL HAEMORRHAGE 38 0.0287
169 HYDRONEPHROSIS 215 0.0287
170 GENE MUTATION 56 0.0283
171 HYPOCHLORAEMIA 33 0.0282
172 EMBOLISM VENOUS 85 0.0280
173 EMBOLISM 232 0.0279
174 NEOPLASM PROGRESSION 970 0.0279
175 METASTASIS 198 0.0277
176 SKIN TOXICITY 156 0.0276
177 MALIGNANT PLEURAL EFFUSION 46 0.0273
178 MANTLE CELL LYMPHOMA 41 0.0269
179 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 276 0.0269
180 FAILURE TO THRIVE 137 0.0264
181 ESCHERICHIA BACTERAEMIA 62 0.0263
182 RENAL TUBULAR INJURY 32 0.0263
183 PSEUDOMONAL SEPSIS 46 0.0262
184 BILIARY OBSTRUCTION 34 0.0262
185 CAPILLARY LEAK SYNDROME 54 0.0261
186 ENTEROCOLITIS 150 0.0260
187 INTESTINAL ISCHAEMIA 143 0.0259
188 LARGE INTESTINE PERFORATION 179 0.0258
189 METASTASES TO LIVER 451 0.0256
190 HYPOPHOSPHATAEMIA 189 0.0255
191 HYPOKALAEMIA 1180 0.0255
192 HEPATITIS B REACTIVATION 80 0.0252
193 SYSTEMIC CANDIDA 63 0.0251
194 STAPHYLOCOCCAL BACTERAEMIA 109 0.0251
195 GASTROINTESTINAL NECROSIS 73 0.0250
196 ENTEROBACTER INFECTION 42 0.0250
197 HYPOCALCAEMIA 473 0.0250
198 DERMATITIS ACNEIFORM 152 0.0250
199 NEUROTOXICITY 434 0.0247
200 ENTERITIS 158 0.0247
201 SEPTIC SHOCK 1072 0.0246
202 HYPOVOLAEMIA 144 0.0246
203 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 234 0.0245
204 BACTERAEMIA 289 0.0243
205 PNEUMOMEDIASTINUM 44 0.0243
206 BLOOD LACTATE DEHYDROGENASE INCREASED 385 0.0243
207 HYPERPHOSPHATAEMIA 52 0.0242
208 HYPOPITUITARISM 42 0.0241
209 BACTERIAL SEPSIS 78 0.0239
210 CORONARY ARTERY THROMBOSIS 48 0.0238
211 JC VIRUS INFECTION 38 0.0238
212 HEPATITIS B 143 0.0237
213 PNEUMONITIS 638 0.0234
214 LYMPHOPENIA 328 0.0232
215 ARTERIOSPASM CORONARY 93 0.0232
216 HYPONATRAEMIA 1304 0.0231
217 CEREBRAL VENOUS THROMBOSIS 42 0.0231
218 SMALL INTESTINAL PERFORATION 43 0.0229
219 ADENOCARCINOMA 51 0.0227
220 METASTATIC NEOPLASM 98 0.0227
221 SECONDARY ADRENOCORTICAL INSUFFICIENCY 34 0.0225
222 CYTOKINE RELEASE SYNDROME 447 0.0223
223 IMMUNE-MEDIATED ADVERSE REACTION 34 0.0221
224 HYPOGAMMAGLOBULINAEMIA 145 0.0220
225 HAEMOLYTIC URAEMIC SYNDROME 51 0.0220
226 POLYNEUROPATHY 263 0.0219
227 CEREBRAL ISCHAEMIA 113 0.0219
228 THROMBOPHLEBITIS 76 0.0217
229 BLOOD MAGNESIUM DECREASED 187 0.0216
230 ANAEMIA 4126 0.0216
231 IMMUNE-MEDIATED HEPATITIS 44 0.0215
232 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 177 0.0214
233 PAPILLARY THYROID CANCER 37 0.0213
234 VENOUS THROMBOSIS 83 0.0211
235 FUNGAEMIA 33 0.0210
236 HICCUPS 171 0.0208
237 JUGULAR VEIN THROMBOSIS 37 0.0208
238 VARICELLA ZOSTER VIRUS INFECTION 43 0.0207
239 CYTOMEGALOVIRUS CHORIORETINITIS 40 0.0205
240 ACUTE RESPIRATORY DISTRESS SYNDROME 362 0.0204
241 HEPATIC MASS 39 0.0202
242 ANOREXIA 258 0.0200
243 LUNG ABSCESS 42 0.0200
244 RENAL FAILURE ACUTE 848 0.0200
245 MALNUTRITION 223 0.0199
246 DRUG RESISTANCE 511 0.0199
247 HEPATIC LESION 86 0.0199
248 PLASMA CELL MYELOMA RECURRENT 64 0.0197
249 NECROSIS 109 0.0196
250 KLEBSIELLA INFECTION 99 0.0196
251 HISTIOCYTOSIS HAEMATOPHAGIC 58 0.0195
252 VASCULAR PSEUDOANEURYSM 34 0.0195
253 RENAL TUBULAR NECROSIS 191 0.0195
254 THROMBOTIC MICROANGIOPATHY 189 0.0194
255 HYPOVOLAEMIC SHOCK 92 0.0192
256 DISSEMINATED INTRAVASCULAR COAGULATION 270 0.0192
257 STOMATITIS 1163 0.0192
258 MYOCARDIAL NECROSIS MARKER INCREASED 32 0.0191
259 BK VIRUS INFECTION 64 0.0190
260 ADRENAL INSUFFICIENCY 230 0.0189
261 SEPSIS 2110 0.0189
262 DEVICE RELATED SEPSIS 38 0.0189
263 PNEUMONIA FUNGAL 74 0.0187
264 DRUG TOXICITY 255 0.0187
265 WHITE BLOOD CELL DISORDER 50 0.0187
266 CARCINOEMBRYONIC ANTIGEN INCREASED 36 0.0186
267 DEHYDRATION 2478 0.0186
268 ATELECTASIS 178 0.0184
269 PULMONARY HAEMORRHAGE 143 0.0183
270 PROCTITIS 51 0.0182
271 TRAUMATIC LUNG INJURY 35 0.0181
272 THROMBOCYTOSIS 66 0.0180
273 ESCHERICHIA SEPSIS 52 0.0179
274 VENOUS THROMBOSIS LIMB 37 0.0179
275 HYPOPROTEINAEMIA 34 0.0179
276 FLUID INTAKE REDUCED 89 0.0178
277 CANDIDIASIS 71 0.0177
278 COMPUTERISED TOMOGRAM ABNORMAL 40 0.0176
279 BLOOD HIV RNA INCREASED 32 0.0176
280 ILEUS 219 0.0176
281 OSTEOLYSIS 36 0.0176
282 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 104 0.0175
283 ILEUS PARALYTIC 78 0.0175
284 CLOSTRIDIAL INFECTION 59 0.0174
285 RECURRENT CANCER 71 0.0174
286 LUNG INFILTRATION 153 0.0173
287 HYPERBILIRUBINAEMIA 178 0.0172
288 HYPERURICAEMIA 70 0.0170
289 THROMBOTIC THROMBOCYTOPENIC PURPURA 60 0.0170
290 DIVERTICULAR PERFORATION 35 0.0170
291 PLATELET COUNT DECREASED 1804 0.0169
292 FIBROSIS 52 0.0169
293 URINARY TRACT OBSTRUCTION 40 0.0168
294 HYPOPHAGIA 431 0.0168
295 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 37 0.0168
296 PULMONARY EMBOLISM 1595 0.0168
297 LYMPHOCYTOSIS 36 0.0167
298 BLOOD ALBUMIN DECREASED 132 0.0166
299 GASTROINTESTINAL OBSTRUCTION 40 0.0166
300 STAPHYLOCOCCAL SEPSIS 82 0.0166
301 LYMPHOMA 256 0.0165
302 METASTASES TO BONE 270 0.0164
303 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 383 0.0164
304 WHITE BLOOD CELL COUNT DECREASED 1774 0.0163
305 PORTAL VEIN THROMBOSIS 52 0.0161
306 LUNG CONSOLIDATION 45 0.0161
307 CYTOMEGALOVIRUS INFECTION REACTIVATION 71 0.0161
308 RENAL IMPAIRMENT 1348 0.0160
309 DEAFNESS 419 0.0160
310 NEUROLOGICAL DECOMPENSATION 37 0.0160
311 GRANULOCYTOPENIA 91 0.0160
312 LUNG CANCER METASTATIC 46 0.0159
313 PLEURITIC PAIN 44 0.0159
314 HYPOPHYSITIS 32 0.0159
315 LYMPHOCYTE COUNT DECREASED 281 0.0159
316 JAUNDICE CHOLESTATIC 56 0.0158
317 URINARY TRACT INFECTION BACTERIAL 40 0.0158
318 LEFT VENTRICULAR DYSFUNCTION 106 0.0158
319 CACHEXIA 81 0.0157
320 ENTEROCOCCAL INFECTION 76 0.0157
321 WHITE BLOOD CELL COUNT ABNORMAL 99 0.0155
322 PROTEIN TOTAL DECREASED 58 0.0154
323 HAEMOGLOBIN ABNORMAL 99 0.0154
324 CLOSTRIDIUM DIFFICILE COLITIS 163 0.0154
325 CARDIAC TAMPONADE 73 0.0153
326 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 115 0.0153
327 BLOOD CREATININE INCREASED 1000 0.0153
328 IMMUNE THROMBOCYTOPENIA 70 0.0153
329 CARDIOMYOPATHY 225 0.0152
330 ASCITES 444 0.0151
331 INTESTINAL PERFORATION 169 0.0150
332 INTERSTITIAL LUNG DISEASE 729 0.0150
333 PNEUMOCYSTIS JIROVECII PNEUMONIA 151 0.0150
334 VENTRICULAR HYPOKINESIA 48 0.0149
335 ABDOMINAL MASS 40 0.0149
336 METASTASES TO SPINE 50 0.0149
337 DUODENAL ULCER 104 0.0147
338 DEEP VEIN THROMBOSIS 957 0.0147
339 AGRANULOCYTOSIS 273 0.0147
340 RESPIRATORY FAILURE 1069 0.0146
341 SUDDEN DEATH 155 0.0146
342 BLOOD SODIUM DECREASED 276 0.0146
343 CREATININE RENAL CLEARANCE DECREASED 58 0.0145
344 ACUTE LYMPHOCYTIC LEUKAEMIA 41 0.0145
345 GRAFT VERSUS HOST DISEASE 104 0.0144
346 PSEUDOMONAS INFECTION 124 0.0144
347 PNEUMOTHORAX 225 0.0142
348 CARDIOPULMONARY FAILURE 55 0.0141
349 HERPES SIMPLEX 91 0.0140
350 ORGANISING PNEUMONIA 69 0.0139
351 HEPATIC FUNCTION ABNORMAL 519 0.0139
352 PLEURAL EFFUSION 846 0.0139
353 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 46 0.0139
354 ORAL FUNGAL INFECTION 38 0.0139
355 B-CELL LYMPHOMA 47 0.0138
356 BLOOD UREA INCREASED 231 0.0138
357 NEPHRITIS 46 0.0138
358 HEPATOTOXICITY 306 0.0137
359 CHEST X-RAY ABNORMAL 42 0.0137
360 VENOOCCLUSIVE DISEASE 34 0.0136
361 HAEMOPTYSIS 377 0.0135
362 ADENOVIRUS INFECTION 39 0.0134
363 MULTIPLE ORGAN DYSFUNCTION SYNDROME 380 0.0134
364 THYROIDITIS 40 0.0133
365 ACUTE CORONARY SYNDROME 110 0.0133
366 MYOSITIS 119 0.0132
367 CEREBRAL INFARCTION 324 0.0132
368 TACHYARRHYTHMIA 33 0.0132
369 PNEUMONIA ASPIRATION 330 0.0132
370 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 35 0.0131
371 NEUROPATHY PERIPHERAL 1251 0.0131
372 EXTRAVASATION 54 0.0131
373 ORAL CANDIDIASIS 173 0.0131
374 ESCHERICHIA INFECTION 108 0.0131
375 COLITIS 495 0.0130
376 DISEASE RECURRENCE 620 0.0130
377 DUODENAL ULCER HAEMORRHAGE 37 0.0129
378 MULTI-ORGAN FAILURE 223 0.0129
379 STRESS CARDIOMYOPATHY 75 0.0129
380 BLOOD PHOSPHORUS DECREASED 47 0.0128
381 HYPERNATRAEMIA 64 0.0128
382 HEARING IMPAIRED 77 0.0128
383 OESOPHAGEAL CANDIDIASIS 51 0.0128
384 HYPERCALCAEMIA 158 0.0128
385 PLASMA CELL MYELOMA 498 0.0128
386 VENTRICULAR DYSFUNCTION 33 0.0127
387 PLATELET DISORDER 32 0.0127
388 HAEMATOCRIT DECREASED 250 0.0126
389 SMALL INTESTINAL OBSTRUCTION 155 0.0126
390 ACUTE KIDNEY INJURY 1918 0.0125
391 BRONCHOPULMONARY ASPERGILLOSIS 97 0.0125
392 DYSPHAGIA 1187 0.0125
393 HYPERTRANSAMINASAEMIA 86 0.0124
394 CYTOMEGALOVIRUS INFECTION 204 0.0123
395 BRONCHOPNEUMONIA 42 0.0123
396 CHRONIC GRAFT VERSUS HOST DISEASE 44 0.0122
397 MYOCARDITIS 139 0.0121
398 HYPERPYREXIA 51 0.0120
399 PHARYNGOLARYNGEAL PAIN 64 0.0120
400 TOXIC ENCEPHALOPATHY 61 0.0120
401 HYPOXIA 424 0.0120
402 EJECTION FRACTION DECREASED 187 0.0120
403 AZOTAEMIA 48 0.0120
404 NON-CARDIAC CHEST PAIN 38 0.0120
405 WOUND DEHISCENCE 40 0.0118
406 PARONYCHIA 52 0.0118
407 PARAPLEGIA 34 0.0118
408 ENCEPHALITIS 81 0.0117
409 ACUTE RESPIRATORY FAILURE 224 0.0116
410 PANCREATIC CARCINOMA METASTATIC 33 0.0116
411 PULMONARY ALVEOLAR HAEMORRHAGE 65 0.0116
412 HAEMOGLOBIN DECREASED 1186 0.0115
413 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 44 0.0115
414 ASPIRATION 125 0.0114
415 PNEUMONIA BACTERIAL 104 0.0113
416 BLOOD CREATINE INCREASED 50 0.0113
417 DERMATITIS 236 0.0113
418 RESPIRATORY SYMPTOM 32 0.0112
419 PLATELET COUNT ABNORMAL 68 0.0112
420 ATRIOVENTRICULAR BLOCK SECOND DEGREE 34 0.0112
421 HYPOTHYROIDISM 356 0.0111
422 SINUS TACHYCARDIA 158 0.0111
423 DEVICE RELATED INFECTION 171 0.0111
424 CANDIDA INFECTION 187 0.0111
425 SUPRAVENTRICULAR TACHYCARDIA 106 0.0111
426 PULMONARY FIBROSIS 211 0.0110
427 ENCEPHALOPATHY 270 0.0110
428 RETINOPATHY 41 0.0110
429 LEUKOCYTOSIS 198 0.0109
430 BLOOD CALCIUM DECREASED 123 0.0109
431 PULSE ABSENT 52 0.0109
432 APLASTIC ANAEMIA 57 0.0109
433 REFUSAL OF TREATMENT BY PATIENT 71 0.0109
434 METABOLIC DISORDER 63 0.0108
435 TUMOUR MARKER INCREASED 52 0.0108
436 HYPERAMMONAEMIA 54 0.0108
437 DUODENITIS 33 0.0107
438 ABDOMINAL TENDERNESS 53 0.0107
439 CATHETER SITE INFECTION 40 0.0106
440 ASPERGILLUS INFECTION 69 0.0105
441 CARDIAC FAILURE ACUTE 70 0.0105
442 LYMPHADENOPATHY 372 0.0105
443 ISCHAEMIA 48 0.0104
444 RESPIRATORY DISTRESS 286 0.0104
445 GENERAL PHYSICAL HEALTH DETERIORATION 1198 0.0103
446 RED CELL DISTRIBUTION WIDTH INCREASED 43 0.0103
447 MULTIPLE-DRUG RESISTANCE 32 0.0103
448 HYPERVOLAEMIA 51 0.0103
449 ACUTE MYOCARDIAL INFARCTION 304 0.0103
450 LUNG INFECTION 160 0.0103
451 LARYNGEAL OEDEMA 63 0.0102
452 NEUTROPHIL COUNT INCREASED 104 0.0101
453 OESOPHAGEAL PAIN 40 0.0101
454 BLOOD CREATININE ABNORMAL 35 0.0101
455 CHEMOTHERAPY 38 0.0100
456 THERAPY NON-RESPONDER 450 0.0100
457 NEOPLASM 115 0.0100
458 HAEMODIALYSIS 84 0.0100
459 OLIGURIA 62 0.0100
460 BLOOD BILIRUBIN INCREASED 269 0.0099
461 GASTROINTESTINAL INFLAMMATION 78 0.0099
462 ENDOCARDITIS 51 0.0099
463 PYREXIA 3439 0.0099
464 VOMITING 4613 0.0098
465 HYPERTHYROIDISM 142 0.0098
466 RENAL FAILURE 1300 0.0098
467 PROTEINURIA 186 0.0098
468 PERICARDIAL EFFUSION 226 0.0098
469 AMYLASE INCREASED 36 0.0097
470 COVID-19 PNEUMONIA 115 0.0097
471 RENAL FUNCTION TEST ABNORMAL 45 0.0097
472 ASPARTATE AMINOTRANSFERASE INCREASED 513 0.0096
473 MULTIPLE MYELOMA 45 0.0096
474 OESOPHAGEAL ULCER 37 0.0096
475 TROPONIN INCREASED 73 0.0096
476 PYELONEPHRITIS 83 0.0096
477 SARCOIDOSIS 45 0.0095
478 CERVIX CARCINOMA 37 0.0095
479 ESCHERICHIA URINARY TRACT INFECTION 40 0.0094
480 STAPHYLOCOCCAL INFECTION 309 0.0094
481 PERITONITIS 194 0.0094
482 C-REACTIVE PROTEIN INCREASED 339 0.0093
483 REGURGITATION 32 0.0093
484 FISTULA 104 0.0092
485 TUBULOINTERSTITIAL NEPHRITIS 173 0.0092
486 BODY TEMPERATURE INCREASED 187 0.0092
487 HEPATIC ENCEPHALOPATHY 85 0.0091
488 TRISMUS 47 0.0091
489 PAPILLOEDEMA 41 0.0091
490 FLANK PAIN 85 0.0091
491 COLITIS ISCHAEMIC 61 0.0090
492 HEPATIC NECROSIS 34 0.0090
493 HEPATIC FAILURE 270 0.0089
494 ISCHAEMIC STROKE 159 0.0089
495 ARTERIAL OCCLUSIVE DISEASE 70 0.0089
496 LUNG NEOPLASM 38 0.0089
497 CARDIAC DYSFUNCTION 33 0.0089
498 RENAL FAILURE CHRONIC 68 0.0088
499 IMMUNOSUPPRESSION 78 0.0088
500 HYPERGLYCAEMIA 322 0.0088
501 ABDOMINAL ABSCESS 39 0.0088
502 PHLEBITIS 45 0.0088
503 BRAIN OEDEMA 110 0.0087
504 HYPERKALAEMIA 305 0.0087
505 ALANINE AMINOTRANSFERASE INCREASED 532 0.0087
506 TRANSAMINASES INCREASED 192 0.0086
507 TYPE 1 DIABETES MELLITUS 52 0.0086
508 SUSPECTED OFF LABEL USE 39 0.0086
509 BACTERIAL INFECTION 159 0.0085
510 UROSEPSIS 78 0.0084
511 HAEMATEMESIS 214 0.0084
512 ORTHOSTATIC HYPOTENSION 147 0.0084
513 PULMONARY TUBERCULOSIS 36 0.0084
514 HAEMODYNAMIC INSTABILITY 64 0.0084
515 MYOCARDIAL ISCHAEMIA 95 0.0083
516 TINNITUS 381 0.0083
517 SINUS BRADYCARDIA 80 0.0083
518 DECREASED APPETITE 1917 0.0082
519 SHOCK 189 0.0082
520 BLOOD POTASSIUM DECREASED 247 0.0082
521 UPPER GASTROINTESTINAL HAEMORRHAGE 138 0.0082
522 HYPERTRIGLYCERIDAEMIA 48 0.0082
523 ACUTE PULMONARY OEDEMA 46 0.0082
524 ANURIA 70 0.0081
525 APHAGIA 39 0.0081
526 PLATELET COUNT INCREASED 105 0.0080
527 ATAXIA 95 0.0080
528 TACHYPNOEA 108 0.0079
529 ATRIOVENTRICULAR BLOCK COMPLETE 53 0.0079
530 HYDROCEPHALUS 43 0.0079
531 PROTHROMBIN TIME PROLONGED 47 0.0079
532 ACIDOSIS 60 0.0078
533 PULMONARY MASS 116 0.0078
534 DIVERTICULUM INTESTINAL 34 0.0078
535 INFECTION 1121 0.0077
536 FOETAL GROWTH RESTRICTION 47 0.0077
537 BLOOD PRESSURE SYSTOLIC DECREASED 35 0.0077
538 PATHOLOGICAL FRACTURE 39 0.0077
539 CIRCULATORY COLLAPSE 129 0.0076
540 TOXIC EPIDERMAL NECROLYSIS 115 0.0076
541 URINE OUTPUT DECREASED 66 0.0075
542 HEMIPARESIS 127 0.0075
543 GRAND MAL CONVULSION 69 0.0075
544 PROCTALGIA 48 0.0075
545 HEMIPLEGIA 62 0.0074
546 GUILLAIN-BARRE SYNDROME 36 0.0074
547 ACUTE GRAFT VERSUS HOST DISEASE 34 0.0074
548 SPLENOMEGALY 87 0.0074
549 PNEUMONIA 2388 0.0074
550 HAEMOLYTIC ANAEMIA 66 0.0074
551 MOUTH ULCERATION 155 0.0073
552 MENTAL STATUS CHANGES 204 0.0073
553 CARDIOGENIC SHOCK 105 0.0073
554 FACIAL PARALYSIS 62 0.0073
555 STREPTOCOCCAL INFECTION 40 0.0072
556 CARDIAC FAILURE 573 0.0071
557 SKIN NECROSIS 37 0.0071
558 GENERALISED OEDEMA 88 0.0071
559 WHITE BLOOD CELL COUNT INCREASED 272 0.0071
560 PLEURISY 42 0.0071
561 BLOOD ALKALINE PHOSPHATASE INCREASED 175 0.0070
562 NEUTROPHILIA 40 0.0070
563 SKIN REACTION 99 0.0070
564 ATRIAL FLUTTER 56 0.0070
565 ORAL PAIN 157 0.0070
566 SHOCK HAEMORRHAGIC 57 0.0070
567 NAUSEA 5501 0.0069
568 WOUND INFECTION 76 0.0069
569 OFF LABEL USE 6031 0.0069
570 TACHYCARDIA 610 0.0069
571 BLOOD DISORDER 55 0.0069
572 HYPOTENSION 1372 0.0068
573 GAMMA-GLUTAMYLTRANSFERASE INCREASED 151 0.0068
574 DRUG ERUPTION 120 0.0068
575 ERYTHEMA MULTIFORME 63 0.0067
576 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 34 0.0067
577 CHOLECYSTITIS ACUTE 38 0.0067
578 LIPASE INCREASED 51 0.0066
579 NEPHROPATHY 62 0.0066
580 GENERAL PHYSICAL CONDITION ABNORMAL 45 0.0066
581 PHARYNGITIS 82 0.0066
582 ALTERED STATE OF CONSCIOUSNESS 143 0.0066
583 MELAENA 145 0.0066
584 COAGULOPATHY 109 0.0065
585 LIVER INJURY 160 0.0065
586 GASTRIC ULCER HAEMORRHAGE 36 0.0065
587 HAEMATURIA 221 0.0064
588 HEPATIC CYTOLYSIS 82 0.0064
589 ORAL DISORDER 47 0.0064
590 ATRIAL FIBRILLATION 623 0.0064
591 PRODUCT USE IN UNAPPROVED INDICATION 1585 0.0064
592 SUBARACHNOID HAEMORRHAGE 65 0.0064
593 LEUKAEMIA 60 0.0064
594 ABSCESS 101 0.0063
595 NO THERAPEUTIC RESPONSE 77 0.0063
596 INTESTINAL OBSTRUCTION 238 0.0063
597 CHOLECYSTITIS 75 0.0063
598 BLOOD URIC ACID INCREASED 36 0.0062
599 ACUTE HEPATIC FAILURE 85 0.0062
600 RESPIRATORY RATE INCREASED 55 0.0062
601 HEPATITIS 157 0.0061
602 FEEDING DISORDER 124 0.0061
603 HEPATOMEGALY 60 0.0061
604 GASTRIC HAEMORRHAGE 70 0.0061
605 HYPERTHERMIA 46 0.0060
606 TOXICITY TO VARIOUS AGENTS 1015 0.0060
607 CARDIO-RESPIRATORY ARREST 251 0.0060
608 DRUG-INDUCED LIVER INJURY 188 0.0060
609 OVARIAN CANCER 55 0.0060
610 EMPHYSEMA 60 0.0059
611 GLOMERULAR FILTRATION RATE DECREASED 73 0.0059
612 CHOLESTASIS 114 0.0059
613 SYNCOPE 594 0.0059
614 DIARRHOEA 3799 0.0059
615 PIGMENTATION DISORDER 36 0.0058
616 GASTROENTERITIS 85 0.0058
617 ABDOMINAL PAIN 1343 0.0058
618 VASCULITIS 67 0.0057
619 RED BLOOD CELL COUNT DECREASED 163 0.0057
620 HAEMOLYSIS 44 0.0057
621 VENTRICULAR FIBRILLATION 63 0.0057
622 METABOLIC ACIDOSIS 180 0.0056
623 RESPIRATORY TRACT INFECTION 146 0.0056
624 CYANOSIS 88 0.0056
625 MOUTH HAEMORRHAGE 41 0.0056
626 SKIN HYPERPIGMENTATION 48 0.0056
627 GASTRITIS 146 0.0055
628 ASTHENIA 2086 0.0055
629 TRANSFUSION 58 0.0055
630 STEVENS-JOHNSON SYNDROME 123 0.0055
631 SQUAMOUS CELL CARCINOMA 52 0.0055
632 NERVOUS SYSTEM DISORDER 170 0.0054
633 RASH MACULO-PAPULAR 121 0.0054
634 PRODUCTIVE COUGH 257 0.0054
635 PANCREATITIS ACUTE 121 0.0054
636 PROCEDURAL COMPLICATION 41 0.0053
637 VENTRICULAR TACHYCARDIA 87 0.0053
638 TOXIC SKIN ERUPTION 53 0.0053
639 GASTROINTESTINAL DISORDER 471 0.0053
640 APPENDICITIS 49 0.0052
641 LIVER DISORDER 232 0.0052
642 CARDIAC ARREST 431 0.0052
643 PULMONARY OEDEMA 231 0.0052
644 EPSTEIN-BARR VIRUS INFECTION 32 0.0051
645 ANAPHYLACTIC SHOCK 132 0.0051
646 MUSCULOSKELETAL CHEST PAIN 79 0.0051
647 MENINGITIS 34 0.0051
648 SKIN INFECTION 57 0.0051
649 MYASTHENIA GRAVIS 41 0.0051
650 THROMBOSIS 408 0.0051
651 TREATMENT FAILURE 420 0.0051
652 OSTEONECROSIS OF JAW 125 0.0050
653 CONSTIPATION 1094 0.0050
654 EPISTAXIS 375 0.0050
655 ARTERIOSCLEROSIS CORONARY ARTERY 33 0.0050
656 INCONTINENCE 52 0.0049
657 URINARY RETENTION 164 0.0049
658 LOWER GASTROINTESTINAL HAEMORRHAGE 36 0.0049
659 CHILLS 570 0.0049
660 PURPURA 43 0.0049
661 MITRAL VALVE INCOMPETENCE 55 0.0049
662 ULCER 76 0.0048
663 POLYURIA 39 0.0048
664 AUTOIMMUNE HEPATITIS 33 0.0047
665 POSTOPERATIVE WOUND INFECTION 32 0.0047
666 HYPOTONIA 47 0.0047
667 BLOOD CALCIUM INCREASED 41 0.0047
668 TRICUSPID VALVE INCOMPETENCE 37 0.0047
669 LOW BIRTH WEIGHT BABY 37 0.0047
670 PERICARDITIS 78 0.0046
671 DELIRIUM 161 0.0046
672 DYSURIA 170 0.0046
673 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 327 0.0046
674 RESPIRATORY SYNCYTIAL VIRUS INFECTION 40 0.0046
675 MASS 64 0.0046
676 CONVULSION 260 0.0045
677 POST PROCEDURAL COMPLICATION 87 0.0045
678 VENTRICULAR EXTRASYSTOLES 47 0.0045
679 PRESYNCOPE 110 0.0045
680 PATHOGEN RESISTANCE 41 0.0045
681 GASTRIC ULCER 85 0.0045
682 JAUNDICE 120 0.0045
683 HAEMORRHAGE INTRACRANIAL 66 0.0044
684 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 241 0.0044
685 SKIN DISORDER 146 0.0044
686 CELLULITIS 220 0.0044
687 HEPATOCELLULAR CARCINOMA 33 0.0043
688 APHASIA 131 0.0043
689 HYPOACUSIS 186 0.0043
690 RESPIRATORY DISORDER 128 0.0043
691 OEDEMA 232 0.0043
692 DYSPNOEA EXERTIONAL 161 0.0043
693 OXYGEN SATURATION DECREASED 240 0.0043
694 CEREBRAL HAEMORRHAGE 150 0.0042
695 INFUSION RELATED REACTION 277 0.0042
696 STATUS EPILEPTICUS 47 0.0042
697 ARTERIOSCLEROSIS 39 0.0041
698 GASTROINTESTINAL HAEMORRHAGE 346 0.0041
699 WEIGHT DECREASED 1146 0.0041
700 ANAPHYLACTIC REACTION 226 0.0041
701 DIALYSIS 58 0.0041
702 BLOOD POTASSIUM INCREASED 66 0.0041
703 CLOSTRIDIUM DIFFICILE INFECTION 88 0.0040
704 RENAL CYST 32 0.0040
705 PULMONARY ARTERIAL HYPERTENSION 58 0.0040
706 LUNG DISORDER 195 0.0040
707 BRADYCARDIA 211 0.0040
708 FACE OEDEMA 67 0.0040
709 OSTEONECROSIS 130 0.0040
710 HEPATOCELLULAR INJURY 56 0.0039
711 FUNGAL INFECTION 131 0.0039
712 PETECHIAE 41 0.0039
713 GENERALISED TONIC-CLONIC SEIZURE 65 0.0039
714 OEDEMA PERIPHERAL 478 0.0039
715 UNRESPONSIVE TO STIMULI 101 0.0039
716 POST PROCEDURAL HAEMORRHAGE 45 0.0039
717 HYPERTENSIVE CRISIS 43 0.0039
718 PELVIC PAIN 70 0.0038
719 FLUID OVERLOAD 56 0.0038
720 HYPERTENSION 811 0.0038
721 RECTAL HAEMORRHAGE 164 0.0038
722 DRUG EFFECT INCOMPLETE 138 0.0038
723 THERAPEUTIC RESPONSE DECREASED 230 0.0038
724 DISORIENTATION 150 0.0038
725 ARRHYTHMIA 179 0.0038
726 GROIN PAIN 33 0.0038
727 BLOOD PRESSURE DECREASED 246 0.0037
728 INTENTIONAL PRODUCT USE ISSUE 323 0.0037
729 CONFUSIONAL STATE 593 0.0037
730 ANAL INCONTINENCE 33 0.0037
731 DYSARTHRIA 138 0.0037
732 URINARY TRACT INFECTION 619 0.0036
733 OBSTRUCTIVE AIRWAYS DISORDER 40 0.0036
734 DYSGEUSIA 265 0.0036
735 DEPRESSED LEVEL OF CONSCIOUSNESS 141 0.0036
736 CHEST PAIN 660 0.0036
737 SUBDURAL HAEMATOMA 51 0.0036
738 IMMUNODEFICIENCY 53 0.0036
739 DRUG INTOLERANCE 343 0.0035
740 BREAST CANCER METASTATIC 38 0.0035
741 CARDIOMEGALY 43 0.0035
742 INTERNATIONAL NORMALISED RATIO INCREASED 99 0.0035
743 INFLAMMATION 179 0.0035
744 DYSPNOEA 1962 0.0035
745 RENAL DISORDER 161 0.0035
746 PALLOR 94 0.0035
747 FOLLICULITIS 36 0.0034
748 RESPIRATORY ARREST 94 0.0034
749 HEPATITIS C 41 0.0034
750 EATING DISORDER 72 0.0034
751 DIPLOPIA 87 0.0033
752 RETCHING 71 0.0033
753 HERPES ZOSTER 191 0.0033
754 PULMONARY HYPERTENSION 69 0.0033
755 EPILEPSY 101 0.0033
756 DRUG INTERACTION 522 0.0033
757 FATIGUE 2550 0.0033
758 REBOUND EFFECT 37 0.0033
759 LETHARGY 188 0.0033
760 DEATH 2772 0.0032
761 SKIN LESION 87 0.0032
762 COMA 150 0.0031
763 PARALYSIS 45 0.0031
764 HAEMORRHAGE 327 0.0031
765 TASTE DISORDER 62 0.0031
766 EYELID OEDEMA 35 0.0030
767 BONE PAIN 176 0.0030
768 COGNITIVE DISORDER 140 0.0030
769 NEOPLASM MALIGNANT 200 0.0030
770 RENAL INJURY 89 0.0030
771 DIVERTICULITIS 83 0.0030
772 ORAL HERPES 58 0.0030
773 OROPHARYNGEAL PAIN 275 0.0030
774 ANGINA PECTORIS 84 0.0029
775 THYROID DISORDER 45 0.0029
776 ILL-DEFINED DISORDER 175 0.0029
777 ELECTROCARDIOGRAM QT PROLONGED 103 0.0029
778 HEPATIC STEATOSIS 53 0.0028
779 NEURALGIA 69 0.0028
780 HEPATIC ENZYME INCREASED 192 0.0028
781 LOWER RESPIRATORY TRACT INFECTION 128 0.0028
782 CHRONIC KIDNEY DISEASE 213 0.0028
783 BRONCHOSPASM 40 0.0028
784 PRODUCT USE ISSUE 526 0.0028
785 COUGH 784 0.0028
786 ALOPECIA 549 0.0028
787 NIGHT SWEATS 90 0.0028
788 DERMATITIS ALLERGIC 35 0.0028
789 HIATUS HERNIA 36 0.0028
790 DRUG LEVEL INCREASED 46 0.0028
791 BLOOD COUNT ABNORMAL 42 0.0028
792 COVID-19 485 0.0028
793 PREMATURE BABY 83 0.0028
794 LUNG NEOPLASM MALIGNANT 113 0.0027
795 LOSS OF CONSCIOUSNESS 352 0.0027
796 RASH 1168 0.0027
797 SENSORY DISTURBANCE 43 0.0027
798 PULMONARY CONGESTION 35 0.0027
799 SKIN ULCER 68 0.0026
800 LABORATORY TEST ABNORMAL 77 0.0026
801 DRUG INEFFECTIVE 3357 0.0025
802 PREMATURE DELIVERY 40 0.0025
803 BLINDNESS 102 0.0025
804 URINARY INCONTINENCE 74 0.0025
805 DEVICE OCCLUSION 35 0.0025
806 LIVER FUNCTION TEST INCREASED 53 0.0025
807 MUSCULAR WEAKNESS 279 0.0025
808 LIVER FUNCTION TEST ABNORMAL 71 0.0024
809 UPPER RESPIRATORY TRACT INFECTION 112 0.0024
810 ABDOMINAL DISTENSION 252 0.0024
811 CORONARY ARTERY OCCLUSION 33 0.0024
812 PERIPHERAL COLDNESS 33 0.0024
813 CENTRAL NERVOUS SYSTEM LESION 33 0.0024
814 PARAESTHESIA 377 0.0024
815 FULL BLOOD COUNT DECREASED 48 0.0024
816 IMPAIRED HEALING 78 0.0024
817 OSTEOMYELITIS 43 0.0024
818 ABDOMINAL PAIN LOWER 60 0.0024
819 BLOOD PRESSURE SYSTOLIC INCREASED 46 0.0024
820 RESTLESSNESS 86 0.0023
821 PRODUCT PRESCRIBING ISSUE 51 0.0023
822 EOSINOPHILIA 41 0.0023
823 GASTRIC CANCER 59 0.0023
824 BACK PAIN 536 0.0023
825 ERYTHEMA 474 0.0023
826 PSYCHOTIC DISORDER 68 0.0023
827 CEREBROVASCULAR ACCIDENT 387 0.0023
828 VAGINAL HAEMORRHAGE 98 0.0023
829 CONDITION AGGRAVATED 683 0.0022
830 CARDIOVASCULAR DISORDER 57 0.0022
831 LACTIC ACIDOSIS 72 0.0022
832 COLD SWEAT 39 0.0022
833 DIABETIC KETOACIDOSIS 53 0.0022
834 MUSCULOSKELETAL PAIN 115 0.0022
835 HYPOGLYCAEMIA 106 0.0022
836 BASAL CELL CARCINOMA 34 0.0022
837 OSTEOPENIA 33 0.0022
838 TRANSIENT ISCHAEMIC ATTACK 73 0.0022
839 RASH GENERALISED 56 0.0022
840 HYPERSENSITIVITY 401 0.0022
841 NECK PAIN 120 0.0021
842 BONE DISORDER 39 0.0021
843 CONJUNCTIVITIS 39 0.0021
844 HAEMATOMA 54 0.0021
845 PANCREATITIS 110 0.0021
846 CHEST DISCOMFORT 212 0.0021
847 ERUCTATION 40 0.0021
848 LOCAL SWELLING 36 0.0021
849 EAR PAIN 40 0.0021
850 RASH PAPULAR 46 0.0021
851 VISUAL ACUITY REDUCED 68 0.0020
852 DYSPEPSIA 201 0.0020
853 SEIZURE 235 0.0020
854 MYOCARDIAL INFARCTION 353 0.0020
855 OESOPHAGEAL CARCINOMA 60 0.0020
856 BLOOD URINE PRESENT 38 0.0020
857 HAEMATOCHEZIA 110 0.0020
858 VIRAL INFECTION 66 0.0020
859 MALAISE 869 0.0020
860 CORONARY ARTERY DISEASE 60 0.0020
861 CHOKING 38 0.0019
862 BLOOD CREATINE PHOSPHOKINASE INCREASED 56 0.0019
863 HYPERHIDROSIS 250 0.0019
864 HEART RATE INCREASED 192 0.0019
865 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 100 0.0019
866 DRY MOUTH 153 0.0019
867 SCAR 32 0.0019
868 CARDIAC FAILURE CONGESTIVE 149 0.0019
869 CYSTITIS 59 0.0019
870 HALLUCINATION, VISUAL 39 0.0018
871 HAEMORRHOIDS 36 0.0018
872 MUSCULOSKELETAL DISORDER 35 0.0018
873 CHOLELITHIASIS 60 0.0018
874 ADVERSE EVENT 167 0.0018
875 HYPOAESTHESIA 270 0.0018
876 DIZZINESS 899 0.0018
877 ABDOMINAL PAIN UPPER 364 0.0018
878 ACTIVITIES OF DAILY LIVING IMPAIRED 35 0.0018
879 SPEECH DISORDER 92 0.0018
880 FLUSHING 178 0.0017
881 RASH MACULAR 61 0.0017
882 BRONCHITIS 129 0.0017
883 RASH ERYTHEMATOUS 83 0.0017
884 LACRIMATION INCREASED 52 0.0017
885 FAECES DISCOLOURED 37 0.0017
886 PAIN 1031 0.0017
887 VERTIGO 102 0.0017
888 DIABETES MELLITUS 127 0.0017
889 THROAT TIGHTNESS 45 0.0017
890 HEAD INJURY 52 0.0016
891 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 47 0.0016
892 RHABDOMYOLYSIS 66 0.0016
893 MATERNAL EXPOSURE DURING PREGNANCY 136 0.0015
894 DYSPHONIA 89 0.0015
895 TREATMENT NONCOMPLIANCE 83 0.0015
896 FOETAL EXPOSURE DURING PREGNANCY 123 0.0015
897 AGITATION 110 0.0015
898 PALPITATIONS 174 0.0015
899 CONTRAINDICATED PRODUCT ADMINISTERED 44 0.0015
900 SOMNOLENCE 291 0.0014
901 FLUID RETENTION 72 0.0014
902 POLLAKIURIA 59 0.0014
903 FLATULENCE 80 0.0014
904 ANGIOEDEMA 62 0.0014
905 MYALGIA 236 0.0014
906 PRURITUS 529 0.0014
907 INCORRECT ROUTE OF DRUG ADMINISTRATION 49 0.0014
908 TYPE 2 DIABETES MELLITUS 46 0.0014
909 BLOOD PRESSURE INCREASED 207 0.0014
910 GASTROOESOPHAGEAL REFLUX DISEASE 108 0.0013
911 FALL 439 0.0013
912 FEELING HOT 79 0.0013
913 ERECTILE DYSFUNCTION 33 0.0013
914 HEADACHE 802 0.0013
915 RASH PRURITIC 69 0.0013
916 SKIN EXFOLIATION 105 0.0012
917 PAIN IN EXTREMITY 364 0.0012
918 TREMOR 203 0.0012
919 SWOLLEN TONGUE 37 0.0012
920 RHINORRHOEA 76 0.0012
921 SKIN DISCOLOURATION 53 0.0012
922 SWELLING FACE 75 0.0012
923 BLISTER 64 0.0011
924 NEPHROLITHIASIS 52 0.0011
925 SINUSITIS 116 0.0011
926 DISTURBANCE IN ATTENTION 61 0.0011
927 DISCOMFORT 69 0.0011
928 FEMUR FRACTURE 35 0.0011
929 WHEEZING 67 0.0011
930 PAIN IN JAW 32 0.0011
931 VISUAL IMPAIRMENT 134 0.0011
932 MEDICATION ERROR 60 0.0011
933 INFLUENZA 120 0.0011
934 COLITIS ULCERATIVE 48 0.0011
935 ECZEMA 56 0.0011
936 SWELLING 97 0.0010
937 GAIT DISTURBANCE 196 0.0010
938 BALANCE DISORDER 87 0.0010
939 HEART RATE DECREASED 35 0.0010
940 SLEEP DISORDER 70 0.0010
941 DEPRESSION 217 0.0010
942 OCULAR HYPERAEMIA 45 0.0009
943 ABDOMINAL DISCOMFORT 155 0.0009
944 BLOOD GLUCOSE INCREASED 174 0.0009
945 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 165 0.0009
946 AMNESIA 59 0.0009
947 URTICARIA 149 0.0009
948 ANXIETY 252 0.0009
949 EXPOSURE DURING PREGNANCY 55 0.0009
950 ABNORMAL BEHAVIOUR 35 0.0009
951 DRY SKIN 117 0.0009
952 MENTAL DISORDER 38 0.0009
953 HOT FLUSH 65 0.0009
954 VISION BLURRED 118 0.0009
955 CARDIAC DISORDER 77 0.0008
956 UNEVALUABLE EVENT 62 0.0008
957 AGGRESSION 41 0.0008
958 DEPRESSED MOOD 43 0.0008
959 ARTHRALGIA 337 0.0008
960 CONTUSION 75 0.0008
961 NO ADVERSE EVENT 138 0.0008
962 DRY EYE 38 0.0008
963 BLADDER CANCER 44 0.0007
964 INSOMNIA 197 0.0007
965 INFLUENZA LIKE ILLNESS 59 0.0007
966 PROSTATE CANCER 56 0.0007
967 MEMORY IMPAIRMENT 95 0.0007
968 HALLUCINATION 52 0.0007
969 THERAPY CESSATION 34 0.0007
970 WEIGHT INCREASED 147 0.0007
971 MOBILITY DECREASED 47 0.0007
972 PERIPHERAL SWELLING 98 0.0006
973 ADVERSE DRUG REACTION 54 0.0006
974 BREAST CANCER 55 0.0006
975 MUSCLE SPASMS 106 0.0006
976 NASOPHARYNGITIS 105 0.0006
977 FEELING ABNORMAL 136 0.0006
978 BURNING SENSATION 39 0.0006
979 UNDERDOSE 37 0.0005
980 INJURY 35 0.0005
981 JOINT SWELLING 58 0.0005
982 ARTHRITIS 37 0.0005
983 THERAPY INTERRUPTED 33 0.0005
984 ILLNESS 47 0.0005
985 HOSPITALISATION 63 0.0004
986 OVERDOSE 88 0.0004
987 ASTHMA 45 0.0004
988 MUSCULOSKELETAL STIFFNESS 33 0.0004
989 RHEUMATOID ARTHRITIS 35 0.0003
990 INCORRECT DOSE ADMINISTERED 50 0.0002
991 INJECTION SITE PAIN 38 0.0001